Authors
Latest:
Type 2 Diabetes Patient Activation and mHealth Interventions Decreased Cardiovascular Disease RiskMobile health (mHealth) and a patient activation program could serve as a model for improving health outcomes for patients in outpatient clinical settings by decreasing atherosclerotic cardiovascular disease risk score.
Latest:
Financial Incentives and Physician Commitment to Guideline-Recommended Hypertension ManagementFinancial incentives may not be strong enough to influence physician goal commitment to guideline-recommended hypertension care when providers attribute performance to forces beyond their control.
Latest:
Health Economic Analysis of Breast Cancer Index in Patients With ER+, LN- Breast CancerThis study projected that the breast cancer index assay is cost saving when used either at diagnosis or at 5 years post diagnosis.
Latest:
Improving Quality Measure Maintenance: Navigating the Complexities of Evolving EvidenceAn exploration of potential negative effects from delays in measure maintenance when changes in clinical evidence affect measure use found that delays may affect patient care and outcomes.
Latest:
Randomized Trial of an Electronic Asthma Monitoring System Among New York City ChildrenChildren who used an electronic monitoring system had as many emergency department visits and hospitalizations for asthma as children who used a paper diary.
Latest:
Geographic Access to Endocrinologists for Florida's Publicly Insured Children With DiabetesEnrollment, claims, and spatial data are used to demonstrate the importance of outreach strategies for families in rural areas who have children with diabetes. Spatial barriers, alone, do not fully elucidate racial/ethnic disparities in pediatric diabetes for street-level location. (For Tables and the Figure, please access the PDF on the last page.)
Latest:
A Strategic Plan for Integrating Cost-effectiveness Analysis Into the US Healthcare SystemA panel composed of medical and pharmacy directors expressed strong support for a greater role for cost-effectiveness analysis in US health policy decisions.
Latest:
False-Positive Mammography and Its Association With Health Service UseThis study demonstrated that a false-positive mammogram was associated with increases in outpatient visits, but not provider referrals, for 1 year post mammogram.
Latest:
Cardiovascular Disease Risk Management During COVID-19: In-Person vs Virtual VisitsThis article compares cardiovascular disease risk management in community clinics during the COVID-19 pandemic among patients for whom primary care was delivered mostly in person vs mostly virtually.
Latest:
ACO Contracting With Private and Public Payers: A Baseline Comparative AnalysisThe authors find 51% of accountable care organizations have private payer contracts, which are more likely than public contracts to include downside risk and upfront payments.
Latest:
Improving Medication Understanding Among Latinos Through Illustrated Medication ListsA randomized controlled trial found that plain-language, illustrated medication lists improved medication understanding among Latinos.
Latest:
Quality Measure Improvement Strategies for Elderly Patients With DiabetesThe authors discuss a simple strategy for payers to ensure more patients with type 2 diabetes achieve control of A1C.
Latest:
Burden of Alzheimer's Disease and Association With Negative Health OutcomesCommunity-based persons with Alzheimer’s disease have a higher risk of fractures, hospitalization, and various comorbidities than persons without the disease.
Latest:
Pattern of Statin Use Among 10 Cohorts of New Users From 1995 to 2004: A Register-Based Nationwide StudyOne-year persistence among new users of statins in Finland improved from 1995 to 1998, after which no substantial changes were observed up to 2004.
Latest:
Geographic Variation in Surgical Outcomes and Cost Between the United States and JapanCompared with Japan, the United States has substantially less geographic variation in surgical outcomes, but it has higher variation in cost.
Latest:
Discussion 6: Nextâ€Generation Genetic Sequencing in Oncology: Ready for Prime Time?Mr Klein leads another discussion with Michael Kolodjiez, MD, Lee N. Newcomer, MD, MHA, John L. Fox, MD, MHA, and Jerry Conway. The panel responds to whether there are gaps in targeted gene analyses. They also discuss other issues including bioinformatics, and how payers, providers, and pharmacists might collaborate on improving care through genetic sequencing.
Latest:
Healthcare Network Analysis of Patients With Diabetes and Their PhysiciansNetwork analyses of patients with diabetes in Hawaii illustrate structures and links that health plans could leverage to strengthen quality improvement and disease management programs.
